Fig. 8: GATA6-dependent regulation of tumor MHCI expression and anti-tumor cytotoxicity.

Schematic diagram illustrating how GATA6-dependent MHCI expression in tumor cells is associated with enhanced antitumor cytotoxicity following combined MEK inhibitor (MEKi) and HDAC inhibitor (HDACi) treatment.